Cortisol, Interleukin-6
Conditions
Brief summary
This Study aimed to assess The Effectivity of Bilateral Transversus Thoracis Muscle Plane Block to Reduce Pain and Stress Response After Open Heart Surgery
Detailed description
This is a double blind randomized controlled trial. Thirty-two subject will be recruited with non-probability consecutive sampling method. Subjects who meet all inclusion criteria and do not have exclusion criteria will be asked to sign the informed consent form before included in this study. Subjects will be randomized into two groups. The first group is the treatment group who will get Bilateral Transversus Thoracis Muscle Plane Block after induction of anesthesia and the second group will be the control group who will not get any regional block during surgery. After surgery, time to first morphine dose, total morphine consumption in 24 hours, extubation time, and adverse events will be recorded for both group.
Interventions
PROCEDUREBilateral transversus thoracis muscle plane block
The block will be performed in between intercostal space 4 and 5, lateral from sternum, with ultrasound guided. Twenty milliliters bupivacaine 0.5% 1mg/body weight will be injected between internal intercostal muscle and transversus thoracis muscle on both sides.
PROCEDUREControl
A needle will be place in the similar area to the transversus thoracis muscle plane block, but no drugs will be injected to the area
Sponsors
Indonesia University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)
Eligibility
Sex/Gender
ALL
Age
19 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
1. Age 19-75 years old 2. Patients who will undergo elective open heart surgery with median sternotomy approach
Exclusion criteria
1. Patient who does not agree to be included in this study 2. weight \<45kg or \>75 kg 3. Patient with chronic obstructive pulmonary disease 4. Patient with chronic kidney disease who needs regular hemodialysis. 5. Patient with local infection in the injection area for transversus thoracis muscle plane block 6. Patient with chronic pain 7. Patient with history of chronic analgetics drugs usage 8. Patient who is contraindicated for local anesthetics 9. Patient with communication disability 10. Patient with cognitive disorders 11. Patient with severe psychiatrics disorders, such as schizophrenia and bipolar disorder
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Interleukin-6 plasma concentration | 48 hours | Interleukin-6 plasma concentration will be measured 3 times, before surgery, 24 hours after surgery, and 48 hours after surgery |
| Cortisol plasma concentration | 48 hours | cortisol plasma concentration will be measured 3 times, before surgery, 24 hours after surgery, and 48 hours after surgery |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| total morphine dose | 24 hours | investigators will record total morphine dose needed in 24 hours |
| time to first morphine | 24 hours | investigators will record time to first morphine dose after surgery |
Countries
Indonesia
Outcome results
None listed